Overview

A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

Status:
Completed
Trial end date:
2018-09-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether roxadustat is safe and effective in the treatment of anemia in participants with chronic kidney disease and not on dialysis.
Phase:
Phase 3
Details
Lead Sponsor:
FibroGen
Collaborators:
Astellas Pharma Europe B.V.
AstraZeneca